The new independent Drug Safety Oversight Board (DSB) within CDER will employ a two-pronged approach to create "a new culture of openness, improved oversight, and enhanced independence," according to FDA officials.

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!

New board to improve internal oversight, consumer communication of drug safety issues

Newsletter